08:00 - 08:15 REGISTRATION AND WELCOME

08:15 - 09:00 TNM Staging Session
Chairs: Paul Van Schil (Antwerp, Belgium), Mirella Marino (Rome, Italy)

What we learned from the 9th edition of theTNM and what we expect to learn from the 10th edition, Enrico Ruffini (Torino, Italy), 14 min
Nodal dissection: What should surgeons do? Joshua Sonett (New York, USA), 12 min
The ITMIG-IASLC nodal map, Edith Marom (Tel Aviv, Israel), 10 min
Q&A, Discussion, 9 min 

09:00 - 10:00 Recent ITMIG Milestones
Chairs: Edith Marom (Tel Aviv, Israel), Andre Moreira (New York, USA)

ITMIG Standards and Definitions, Wentao Fang (Shanghai, China), 12 min
ITMIG Pathology Guidelines, Anja Roden (Rochester, USA), 12 min
ITMIG Survey on Clinical and Pathology Practice of the Diagnosis and Treatment of Thymic Epithelial Tumors, Malgorzata Szolkowska (Warsaw Poland), 12 min
ITMIG Postoperative Radiation Therapy (PORT) project, Frank Detterbeck, (New Haven, USA), 12 min 
Q&A, Discussion, 12 min  

10:00 - 11:00 Oral Abstract Session 1
Chairs: Alexander Marx (Gottingen, Germany), Claudio Silva (Santiago, Chile)

Machine Learning Models from FDG PET/CT for Predicting Recurrence in Thymomas, Angelo Castello (Milan, Italy), 7 min + 3 min
MIST: A Weakly Supervised Deep Learning System for Multicenter Diagnosis of Mediastinal Tumors, Xiaofeng Jiang (Chengdu, China), 7 min + 3 min
Central pathology review of thymic tumors: updated analysis of diagnostic concordance in the French RYTHMIC cohort, Álvaro Gutiérrez (Villejuif, France), 7 min + 3 min
Weakly Supervised AI-Based Subtyping of Thymic Epithelial Tumors Using H&E Whole Slide Images, Anna Salut Esteve Domínguez (Rotterdam, the Netherlands), 7 min + 3 min 
FGFR1 amplification in thymic epithelial tumors (TET): A study from 48 cases, Véronique Hofman (Nice, France), 7 min + 3 min
Thymic Cancer in France: A Comprehensive Analysis of Incidence Based on French National Healthcare Data, Álvaro Gutiérrez (Villejuif, France), 7 min + 3 min

11:00 - 11:30 Coffee Break

Poster presentations 

11:30 - 12:15 ITMIG-TYME Joint Session
Chairs: Paolo Mendogni (Milan, Italy), Paolo Andrea Zucali (Milan, Italy)

Italian network TYME – Aims and Accomplishments, Giulia Galli (Pavia, Italy), 12 min
TETs Italian Registry – Aims and Accomplishments, Annalisa Trama (Milan, Italy), 12 min
ITMIG collaboration with national networks and future directions, Nicolas Girard (Paris, France), 12 min
Q&A, Discussion, 9 min  

12:15 - 13:00 Bilateral Robotic Thymectomy in Rheumatoid Arthritis: A Multidisciplinary Approach to Complex Surgery.
Case Presentation with Audience Participation
Chairs: Roger Hsu (Toronto, Canada), Alberto De La Vega (San Paolo, Brazil)

Presentation with clinical, radiological and pathological comments

CASE PRESENTATION: Davide Tosi (Milan, Italy), 10 min
Radiology: Maria Carmela Andrisani (Milan, Italy), 10 min
Pathology: Giorgio Croci (Milan, Italy), 10 min
Pulmonology: Antonella Arcadu (Milan, Italy), 10 min 
Q/A, Discussion, 5 min

13:00 - 13:45 LUNCH BREAK

13:15 - 13:45 SESSION WITH REPRESENTATIVES OF PATIENTS: Hear the Patients’ Voice
Chair: Malgorzata Szolkowska (Warsaw, Poland), Laura Abate-Daga (Italy)

Presentation of survey's results, Malgorzata Szolkowska (Warsaw, Poland), 3 min
The value of patient support groups. Tutor Tumori’s story, Laura Abate-Daga (Italy), 3 min
The value of patient support groups. The ThymicUK story, Karen Ruddock (UK), 3 min
The value of a dedicated nurse/case manager in thymic malignancies, Marrika Colvin, (UK), 3 min
I Don’t Want to Be Alone!, Dagmar Pechova (Czech Republic), 3 min
Discussion, 15 min

13:45 - 14:45 Management of Recurrent and Re-recurrent Disease
Chairs: Paolo Mendogni (Milan, Italy), Rohan Maniar (Indiana, USA)

CASE PRESENTATION: Giuseppe Calabrese (Rome, Italy), 10 min 
Recurrence and primary TETs: Is it the same disease? Marco Chiappetta (Catanzaro, Italy), 10 min 
Innovative therapies in recurrences of thymic tumors, Christopher Nabel (Boston, USA), 10 min  
Round table/audience discussion, 20 min 
The ITMIG recurrence classification: validation and possible updates, Filippo Lococo (Rome, Italy), 10 min  

14:45 - 15:45 Anti-angiogenesis, Immunotherapy and Novel Therapies in Thymic Carcinoma
Chairs: Giovanella Palmieri (Naples, Italy), Nicolas Girard (Paris, France)

The immunotherapy landscape: from clinical trials to clinical practice, Margaret Ottaviano (Naples, Italy), 12 min
Anti-angiogenics and combinations, Sukhmani K. Padda, Fox (Philadelphia, USA), 12 min
New treatment strategies: Antibody Drug Conjugates and bispecific Antibody Drug Conjugates, Chul Kim (Washington, USA), 12 min
Platinum based chemotherapy: still the best option? Martina Imbimbo (Bellinzona, Switzerland), 12 min
Q&A, Discussion, 12 min 

15:45 - 16:15 Coffee break

Poster presentations 

16:15 - 17:15 Neoadjuvant therapies: When, how and why
Chairs: Patrick Loehrer (Indiana, USA); Wentao Fang (Shanghai, China)

What do surgeons need to know from imaging in advanced thymic epithelial tumors? Katarzyna Blasinska (Warsaw, Poland), 12 min 
Potential neoadjuvant use of immunotherapy and targeted therapy in 2025, Magdalena Knetki-Wróblewska, (Warsaw, Poland), 12 min 
Surgical challenges after neoadjuvant therapy, Andrea Billè (London, UK), 12 min
How to assess pathologic response after neoadjuvant therapy, Andre Moreira, (New York, USA), 12 min 
Q&A, Discussion, 12 min 

17:15 - 18:15 Nuclear Medicine and Interventional Radiology in TETs - a tailored approach
Chairs: Jeanne Ackman (Boston, USA), Claudio Silva (Santiago, Chile)

Prognostic value and role of FDG-PET-CT: Initial staging and after therapy, Luca Urso (Ferrara, Italy), 12 min
Beyond FDG, Angelo Castello (Milan, Italy), 12 min
Percutaneous ablation therapy in isolated or multiple extra-mediastinal thymic epithelial lesions: is it worthwhile? Giampaolo Carrafiello (Milan, Italy), 12 min
How to manage difficult cases? An intrapleural recurrence case, Dirk Van Raemdonck, (Leuven, Belgium), 10 min
Q&A, Discussion, 14 min

19:00 - 20:00 WELCOME RECEPTION